Related references
Note: Only part of the references are listed.Timely Assessment of the Severity of the 2009 H1N1 Influenza Pandemic
Gregory L. Armstrong et al.
CLINICAL INFECTIOUS DISEASES (2011)
Immunogenicity and Cross-Reactivity of 2009-2010 Inactivated Seasonal Influenza Vaccine in US Adults and Elderly
Hang Xie et al.
PLOS ONE (2011)
Recipients of Vaccine against the 1976 Swine Flu Have Enhanced Neutralization Responses to the 2009 Novel H1N1 Influenza Virus
Jonathan A. McCullers et al.
CLINICAL INFECTIOUS DISEASES (2010)
Similar immunogenicity and safety of the A/H1N1 2009 pandemic influenza strain when used as a monovalent or a trivalent vaccine
Diane Van der Vliet et al.
HUMAN VACCINES (2010)
Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins
Steven J. Gamblin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Inactivated Seasonal Influenza Vaccines Increase Serum Antibodies to the Neuraminidase of Pandemic Influenza A(H1N1) 2009 Virus in an Age-Dependent Manner
Glendie Marcelin et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects
Thomas R. Cate et al.
VACCINE (2010)
Reflections on Pandemic (H1N1) 2009 and the International Response
Gabriel M. Leung et al.
PLOS MEDICINE (2010)
A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens
Matthew R. Sandbulte et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2009)
Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus.
Kathy Hancock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans
Matthew R. Sandbulte et al.
PLOS MEDICINE (2007)
A DNA transfection system for generation of influenza A virus from eight plasmids
E Hoffmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
